サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452579

中南米の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

South & Central America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 102 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
中南米の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別
出版日: 2024年01月05日
発行: The Insight Partners
ページ情報: 英文 102 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の分子診断市場は、2022年の12億2,128万米ドルから2030年には26億7,914万米ドルに成長すると予測されています。2022年から2030年までのCAGRは10.3%と推定されます。

分子診断技術の進歩が中南米の分子診断市場を後押し

分子診断技術およびプラットフォームは、解剖学および臨床病理学のあらゆる分野で利用されています。一塩基多型、欠失、再配列、挿入など、疾患に関連するDNAまたはRNA配列は、分子診断検査で検出することができます。COVID-19の出現後、分子診断法はさらに改良されました。従来、検査にはCTスキャン、血液学的検査、RT-PCRが用いられていました。COVID-19の症例が2020年に急増するにつれ、従来の検査の欠点を克服するため、迅速で精密な検査プラットフォームへのニーズが急増しました。コンピュータ断層撮影法（CT）はコストがかかり、すべての病院で実施できるとは限らないため、無症状の患者のウイルス感染やその他の疾患を検出することができないです。広く用いられているRT-PCR法も、時間と費用がかかり、感染初期の低ウイルス量を検出することができなかった。その結果、研究者たちは、より迅速で費用対効果の高い、SARS-CoV-2を検出する新しいアプローチを開発しました。逆転写ループ媒介等温増幅法（RT-LAMP）、マイクロアレイベースの検出、アプタマーベースの診断、SHERLOCK、SHERLOCKv2、FETバイオセンサー、細胞ベースの電位差診断、分子インプリンティング技術は、COVID-19診断のために開発された新しい分子診断技術の一例です。ここ数年、FDAの報告によると、分子検査、抗原依存性検査、血清学的検査の進歩が承認されています。COVID-19パンデミックを管理し、死亡の程度を軽減するためのさまざまな国の科学界による協力的な取り組みは、分子ツールおよび診断の状況全体に恩恵をもたらしており、これは将来、分子診断市場に大きな機会をもたらすと思われます。

中南米の分子診断市場概要

中南米の分子診断市場はアルゼンチン、ブラジル、その他南米に区分されます。同地域の市場成長の背景には、高齢化、診断市場の成長、医療機器業界の大手企業によるイニシアチブの高まりがあります。さらに、有望な診断検査オプションを必要とする慢性疾患の流行も、同地域の市場成長に寄与しています。

中南米の分子診断市場の収益と2030年までの予測（金額）

中南米の分子診断市場セグメンテーション

中南米の分子診断市場は、疾患領域、技術、製品・サービス、エンドユーザー、国に区分されます。

疾患領域別に見ると、中南米の分子診断市場は感染症、腫瘍、遺伝子検査、心疾患、免疫系疾患、その他に区分されます。感染症分野は2022年に南米・中米の分子診断市場で最大のシェアを記録しました。

技術別では、中南米の分子診断市場はポリメラーゼ連鎖反応（PCR）、in situハイブリダイゼーション、等温核酸増幅技術（INAAT）、DNAシーケンシングと次世代シーケンシング（NGS）、DNAマイクロアレイ、その他に区分されます。ポリメラーゼ連鎖反応（PCR）セグメントは、2022年に中南米の分子診断市場シェアで最大を記録しました。ポリメラーゼ連鎖反応（PCR）はさらにRT-PCR、qPCR、マルチプレックスPCR、その他に細分化されます。

製品とサービスに基づいて、中南米の分子診断市場はアッセイとキット、機器、サービスとソフトウェアに区分されます。アッセイとキット分野は、2022年に南米分子診断市場最大のシェアを記録しました。

エンドユーザー別では、中南米の分子診断市場は診断ラボ、病院・クリニック、研究・学術機関、その他に区分されます。2022年の中南米の分子診断市場シェアは、診断ラボ部門が最大でした。

国別では、中南米の分子診断市場はブラジル、アルゼンチン、その他中南米に分類されます。ブラジルは2022年の中南米の分子診断市場を独占しました。

Abbott Laboratories、bioMerieux SA、Danaher、F. Hoffmann-La Roche Ltd、Illumina Inc、Novartis AG、Qiagen NV、Siemens Healthineers AG、Thermo Fisher Scientific Inc.は、南米・中米分子診断市場に参入している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の分子診断市場情勢

  • 概観
  • PEST分析
    • 中南米のPEST分析

第5章 中南米の分子診断市場- 主要産業力学

  • 主な市場促進要因
    • 新製品の開発とポイントオブケア検査需要の増加
    • 関連疾患の急増
  • 市場抑制要因
    • 分子検査に伴う限界
  • 市場機会
    • 分子診断技術の進歩
  • 今後の動向
    • 個別化医療における分子診断法
  • インパクト分析

第6章 分子診断市場：中南米市場分析

  • 中南米の分子診断市場売上高、2022年～2030年

第7章 中南米の分子診断市場：収益と2030年までの予測 - 疾患領域別

  • 市場収益シェア（%）、2022年および2030年
  • がん領域
  • 感染症
  • 遺伝子検査
  • 心臓疾患
  • 免疫系疾患
  • その他

第8章 中南米の分子診断市場：収益と2030年までの予測 - 技術別

  • 市場収益シェア（%）、2022年および2030年
  • ポリメラーゼ連鎖反応
  • 等温核酸増幅技術（INAAT）
  • DNAシーケンシングおよび次世代シーケンシング（NGS）
  • DNAマイクロアレイ
  • インサイチュハイブリダイゼーション（ISH）
  • その他

第9章 中南米の分子診断市場：収益と2030年までの予測 - 製品・サービス別

  • 市場収益シェア（%）、2022年および2030年
  • アッセイとキット
  • 機器
  • サービスおよびソフトウェア

第10章 中南米の分子診断市場：収益と2030年までの予測 - エンドユーザー別

  • 市場収益シェア（%）、2022年および2030年
  • 病院および診療所
  • 診断研究所
  • 研究・学術機関
  • その他

第11章 中南米の分子診断市場：国別分析

  • ブラジル
  • アルゼンチン
  • その他中南米
  • その他の地域

第12章 中南米の分子診断市場：業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機的展開
  • 無機的展開

第13章 中南米の分子診断市場、主要企業プロファイル

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG

第14章 付録

図表

List Of Tables

  • Table 1. South & Central America Molecular Diagnostics Market Segmentation
  • Table 2. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
  • Table 3. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
  • Table 4. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 7. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
  • Table 9. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 12. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
  • Table 14. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Organic Developments Done By Companies
  • Table 18. Inorganic Developments Done By Companies
  • Table 19. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. South & Central America - PEST Analysis
  • Figure 2. South & Central America Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 6. Oncology: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Infectious Disease: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Genetic Testing: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Cardiac Diseases: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immune System Disorders: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. RT-PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. qPCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Multiplex PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. DNA microarrays: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 24. Assays and Kits: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Instruments: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Services and Software: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals and Clinics: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Research and Academic Institutes: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Molecular Diagnostics Market, By Country, 2022 (US$ Mn)
  • Figure 33. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 34. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Growth Strategies Done by the Companies in the Market (%)
目次
Product Code: TIPRE00026719

The South & Central America molecular diagnostics market is expected to grow from US$ 1,221.28 million in 2022 to US$ 2,679.14 million by 2030. It is estimated to grow at a CAGR of 10.3% from 2022 to 2030.

Advancements in Molecular Diagnostics Technologies Fuels South & Central America Molecular Diagnostics Market

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

South & Central America Molecular Diagnostics Market Overview

The molecular diagnostics market in South & Central America is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the aging population, growing diagnostics market, and the increasing initiatives by major players in the medical device industry. Furthermore, the prevalence of chronic diseases that demand promising diagnostic test options contributes to the market growth in the region.

South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Molecular Diagnostics Market Segmentation

The South & Central America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the South & Central America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on technology, the South & Central America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest South & Central America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the South & Central America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on end users, the South & Central America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest South & Central America molecular diagnostics market share in 2022.

Based on country, the South & Central America molecular diagnostics market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America molecular diagnostics market in 2022.

Abbott Laboratories, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd, Illumina Inc, Novartis AG, Qiagen NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America molecular diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis

5. South & Central America Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - South & Central America Market Analysis

  • 6.1 South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 qPCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Molecular Diagnostics Market - Country Analysis

  • 11.1 South & Central America Molecular Diagnostics Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
      • 11.1.1.1 South & Central America Molecular Diagnostics Market by Country
    • 11.1.2 Brazil
      • 11.1.2.1 Overview
    • 11.1.3 Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.4 Brazil: Molecular Diagnostics Market, by Disease Area
    • 11.1.5 Brazil: Molecular Diagnostics Market, by Technology
      • 11.1.5.1 Brazil: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.6 Brazil: Molecular Diagnostics Market, by Product and Services
    • 11.1.7 Brazil: Molecular Diagnostics Market, by End User
    • 11.1.8 Argentina
      • 11.1.8.1 Overview
    • 11.1.9 Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.10 Argentina: Molecular Diagnostics Market, by Disease Area
    • 11.1.11 Argentina: Molecular Diagnostics Market, by Technology
      • 11.1.11.1 Argentina: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.12 Argentina: Molecular Diagnostics Market, by Product and Services
    • 11.1.13 Argentina: Molecular Diagnostics Market, by End User
    • 11.1.14 Rest of South & Central America
      • 11.1.14.1 Overview
    • 11.1.15 Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.16 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
    • 11.1.17 Rest of South & Central America Molecular Diagnostics Market, by Technology
      • 11.1.17.1 Rest of South & Central America: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.18 Rest of South & Central America: Molecular Diagnostics Market, by Product and Services
    • 11.1.19 Rest of South & Central America: Molecular Diagnostics Market, by End User

12. South & Central America Molecular Diagnostics Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. South & Central America Molecular Diagnostics Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 F. Hoffmann-La Roche Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 bioMerieux SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Illumina Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Danaher
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Siemens Healthineers AG
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Novartis AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms